Filings

Form TypeForm DescriptionFiling DateReport DateView Report
S-8Securities to be offered to employees in employee benefit plans2023-12-22
10-K/AAnnual report [Section 13 and 15(d), not S-K Item 405] - amended2023-12-212023-06-30
8-KCurrent report2023-12-202023-12-19
4Statement of changes in beneficial ownership of securities2023-12-062023-12-05
8-KCurrent report2023-11-292023-11-29
10-QQuarterly report [Sections 13 or 15(d)]2023-11-142023-09-30
10-QQuarterly report [Sections 13 or 15(d)]2023-11-142023-09-30
8-KCurrent report2023-11-142023-11-14
424B3Prospectus [Rule 424(b)(3)]2023-11-13
EFFECTNotice of Effectiveness2023-11-13
S-1General form for registration of securities under the Securities Act of 19332023-11-08
8-KCurrent report2023-11-022023-11-02
8-KCurrent report2023-10-302023-10-24
DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material2023-10-27
DEF 14AOther definitive proxy statements2023-10-272023-12-19
DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material2023-10-27
8-KCurrent report2023-10-242023-10-24
NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4052023-09-292023-06-30
10-KAnnual report [Section 13 and 15(d), not S-K Item 405]2023-09-292023-06-30
8-KCurrent report2023-09-292023-09-29
8-KCurrent report2023-09-252023-09-22
8-KCurrent report2023-09-252023-09-25
8-KCurrent report2023-09-082023-09-07
4Statement of changes in beneficial ownership of securities2023-08-312023-08-31
8-KCurrent report2023-07-242023-07-21
8-KCurrent report2023-07-202023-07-20
8-KCurrent report2023-06-222023-06-22
8-KCurrent report2023-06-012023-06-01
8-KCurrent report2023-05-252023-05-24
8-KCurrent report2023-05-192023-03-18

Investor Alerts

Sign up for investor alerts!
Sign Up

Information Request

Send us a request for information
Learn More

#1455 – 885 West Georgia St.
Vancouver, BC, Canada
V6C 3E8

Pharmaceutical

MANUFACTURING

Investor

CORPORATE

Learn

© Copyright 2024 InMed Pharmaceuticals Inc.

Subscribe

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*
Consent*